NN Investment Partners Holdings’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$2.86M Sell
40,931
-2,857
-7% -$209K 0.02% 496
2021
Q4
$3.41M Buy
43,788
+795
+2% +$70.2K 0.02% 480
2021
Q3
$4.1M Buy
42,993
+4,521
+12% +$477K 0.02% 448
2021
Q2
$4.78M Buy
38,472
+1,568
+4% +$187K 0.03% 415
2021
Q1
$4.86M Buy
36,904
+9,961
+37% +$1.36M 0.03% 414
2020
Q4
$3.57M Buy
26,943
+19,116
+244% +$2.31M 0.02% 433
2020
Q3
$798K Buy
+7,827
New +$676K 0.01% 615

Other funds holding EXAS

NN Investment Partners Holdings's EXAS Position: Q1 2022 in Review

NN Investment Partners Holdings reduced its Exact Sciences (EXAS) stake by 6.5% in Q1 2022, selling an estimated $209K and leaving 40,931 shares worth $2.86M. The position accounts for 0.02% of the portfolio, ranked #496.

NN Investment Partners Holdings first reported a position in EXAS in Q3 2020 and has held it in 7 quarters since. The position peaked at $4.86M in Q1 2021. 559 funds tracked by Wall St. Rank hold EXAS as of Q1 2022.

  • NN Investment Partners Holdings held 40,931 shares of Exact Sciences worth $2.86M as of Q1 2022.
  • NN Investment Partners Holdings sold 2,857 Exact Sciences shares in Q1 2022, an estimated $209K.
  • Exact Sciences made up 0.02% of NN Investment Partners Holdings's portfolio in Q1 2022, its #496 holding.
  • NN Investment Partners Holdings first reported a position in Exact Sciences in Q3 2020 and has held it in 7 quarters since.
  • NN Investment Partners Holdings's Exact Sciences position peaked at $4.86M in Q1 2021.
  • 559 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2022.

Based on NN Investment Partners Holdings's 13F filing for Q1 2022, filed 11 May 2022.